- Home
- ABVC vs TRT Comparison
ABVC vs TRT Comparison
Compare ABVC & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- TRT
- Stock Information
- Founded
- ABVC 2015
- TRT 1958
- Country
- ABVC United States
- TRT United States
- Employees
- ABVC N/A
- TRT N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- TRT Industrial Machinery/Components
- Sector
- ABVC Health Care
- TRT Technology
- Exchange
- ABVC Nasdaq
- TRT Nasdaq
- Market Cap
- ABVC 22.1M
- TRT 21.6M
- IPO Year
- ABVC N/A
- TRT N/A
- Fundamental
- Price
- ABVC $3.15
- TRT $5.21
- Analyst Decision
- ABVC
- TRT
- Analyst Count
- ABVC 0
- TRT 0
- Target Price
- ABVC N/A
- TRT N/A
- AVG Volume (30 Days)
- ABVC 436.6K
- TRT 29.9K
- Earning Date
- ABVC 08-13-2025
- TRT 05-13-2025
- Dividend Yield
- ABVC N/A
- TRT N/A
- EPS Growth
- ABVC N/A
- TRT N/A
- EPS
- ABVC N/A
- TRT 0.00
- Revenue
- ABVC $508,383.00
- TRT $35,548,000.00
- Revenue This Year
- ABVC $735.18
- TRT N/A
- Revenue Next Year
- ABVC N/A
- TRT N/A
- P/E Ratio
- ABVC N/A
- TRT $1,182.62
- Revenue Growth
- ABVC 1904.43
- TRT N/A
- 52 Week Low
- ABVC $0.40
- TRT $4.62
- 52 Week High
- ABVC $3.12
- TRT $7.88
- Technical
- Relative Strength Index (RSI)
- ABVC 69.63
- TRT 47.54
- Support Level
- ABVC $2.16
- TRT $5.15
- Resistance Level
- ABVC $3.10
- TRT $5.70
- Average True Range (ATR)
- ABVC 0.26
- TRT 0.44
- MACD
- ABVC 0.09
- TRT -0.02
- Stochastic Oscillator
- ABVC 85.29
- TRT 22.70
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.